Our colleagues Michal Karpíšek and Iveta Křepelková have been contributed to the paper published in the Journal of Personalize Medicine, where BioVendors miREIA technology has been used for miRNA profiling in the big study focused on cardiovascular disease.
Read more
Type-2 diabetes mellitus (T2DM) is a major health problem in the world and many studies have been done in this topic. Nowadays we can certainly say, that pathogenesis of T2DM is connected to obesity-associated insulin resistance and dysglycemia. Despite the fact, that individuals of South Asian descent have a higher risk of developing T2DM for a given body mass index (BMI) compared to Caucasians, majority of the published data was obtained by studying western populations. Moreover, in South Asians, different mechanisms could operate in the pathogenesis of these processes. The pressure for new data in this field is even higher because of recent escalation of obesity in this region.
Read more
Are you wondering what the term “diabesity” stands for? It expresses the strong association between type 2 diabetes mellitus (T2DM) and obesity. 75–90% of patients with T2DM are overweight or obese, as obesity is one of the main risk factors for T2DM. Moreover, progression of obesity to T2DM can be partly explained by changes in adipose tissue composition and function.
Read more